March 13, 2017 by Scot Meyer and Chain Drug Review
CVS Caremark, CVS Health, CVS Health COO, CVS Pharmacy, Jon Roberts, Larry Merlo, MinuteClinic, Omnicare
2017, Issue 03-13-2017, Issues, News
WOONSOCKET, R.I. — CVS Health has named Jon Roberts to the new position of executive vice president and chief operating officer. Roberts, who was president of the CVS Caremark pharmacy benefits management unit, will continue to report to CVS Health president and chief executive officer Larry Merlo. The company said that in his new position
March 2, 2017 by Geoff Walden and Chain Drug Review
CVS Caremark, CVS Health, CVS Pharmacy, Jon Roberts, Larry Merlo, PBM, pharmacy benefits management
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — Veteran CVS Health executive Jon Roberts has been named the company’s executive vice president and chief operating officer, a new position. CVS said Thursday that Roberts, who was president of the CVS Caremark pharmacy benefits management unit, will continue to report to CVS Health president and chief executive officer Larry Merlo. As
February 28, 2017 by Chain Drug Review
Chain Drug Marketing Association, Chain Drug Review, CVS Health, Jim Devine, Larry Merlo, National Association of Chain Drug Stores, Retailer of the Year, Richard Ashworth, slideshow, Steve Anderson, Walgreens
Slideshows
Chain Drug Review held a reception in Manhattan earlier this month to honor recipients of the publication’s Retailer of the Year awards. CVS Health president and chief executive officer Larry Merlo named Health Care Executive of the Year, and Walgreens president of pharmacy and retail operations Richard Ashworth was named as Operations Executive of the Year.
February 16, 2017 by Chain Drug Review
CVS Health, Fortune Most Admired Companies, Larry Merlo, World's Most Admired Companies
Business, Retail News
WOONSOCKET, R.I. — CVS Health has been named as one of the “World’s Most Admired Companies” by Fortune magazine. CVS came in at No. 45 on the corporate rankings list, which put it among the top 50 “all-stars” on this year’s Fortune Most Admired Companies list. In addition, CVS finished No. 1 in its industry
February 9, 2017 by Chain Drug Review
CVS Caremark, CVS Health, CVS Pharmacy, Larry Merlo, Omnicare, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health topped Wall Street’s earnings-per-share forecast and, driven largely by its PBM unit, saw double-digit sales gains for the 2016 fourth quarter and full year. CVS said Thursday that for the fourth quarter ended Dec. 31, revenue totaled $45.97 billion, up 11.7% from $41.15 billion a year earlier. For the 2016
January 16, 2017 by David Pinto and Chain Drug Review
Albertsons, America’s drug chains, Bob Miller, CVS Health, David Pinto, Doug McMillon, George Riedl, Helena Foulkes, John Standley, Larry Merlo, Ornella Barra, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walmart
2017, Issue 01-16-2017, Issues, Opinion
Going into the new year, several key personnel questions await answers, foremost among them the age-old problem of determining who, in 2017, will emerge as the most influential senior staffers at America’s drug chains. The determination is made more difficult by the fact that, as of this writing, Walgreens’ acquisition of Rite Aid remains unresolved.
January 3, 2017 by Jeffrey Woldt and Chain Drug Review
Chain Drug Review, CVS Caremark, CVS Health, CVS Pharmacy, health care delivery, Health Care Executive of the Year, Larry Merlo, MinuteClinic, Omnicare, Target Corp.
2017, Featured Articles, Issue 01-02-2017, Issues, Leading Headlines, News, Retail News
WOONSOCKET, R.I. — As Larry Merlo sees things, health care delivery in the United States is a tale of two incompatible models, a costly, inefficient one rooted in the past, and another focused on a future of increased patient access, improved outcomes and lower costs. “At the moment, it’s as if we have two health
December 15, 2016 by Chain Drug Review
Brian Tanquilut, CVS Analyst Day, CVS Health, Dave Denton, Jefferies, Larry Merlo, PBM market, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News
NEW YORK — CVS Health’s integrated pharmacy care model makes it a “partner of choice” in the health care arena, president and chief executive officer Larry Merlo said at the company’s annual Analyst Day event in Manhattan. Merlo and senior CVS Health executives gathered in New York on Thursday to give the investment community an
November 21, 2016 by Scot Meyer and Chain Drug Review
CVS Health, CVS layoffs, Larry Merlo, Tricare, Walgreens Boots Alliance
2016, Issue 11-21-2016, Issues, News
WOONSOCKET, R.I. — CVS Health said it will eliminate about 600 corporate jobs over the next couple of months. The job cuts will be made primarily at CVS corporate offices in Rhode Island, Illinois and Arizona, the company said. In a statement, CVS Health indicated that the job reductions reflect fluctuations in the health care
November 8, 2016 by Chain Drug Review
CVS Caremark, CVS Health, CVS Pharmacy, Deutsche Bank Securities, George Hill, Larry Merlo
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health posted sales gains in both of its business units and adjusted earnings per share above Wall Street’s forecast for the 2016 third quarter. However, CVS said Tuesday that it lowered its outlook for full-year 2016 and, in preliminary guidance for fiscal 2017, expects to lose over 40 million retail prescriptions
October 14, 2016 by CDR Blog and Chain Drug Review
CVS Health, Larry Merlo
CDR Blog
Some consumers are making trade-offs as they try to solve the cost-quality-access equation for health care, according to CVS Health. This week, CVS posted some key findings from a poll of 2,000 registered voters that it conducted last month. Probably the most brow-raising concerns the hard choices that consumers are making. In CVS’ survey, 28%
August 2, 2016 by Chain Drug Review
CVS Health, CVS Pharmacy, Larry Merlo, Omnicare, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — Rising PBM and specialty pharmacy sales and recently acquired pharmacy businesses lifted revenue at CVS Health Corp. for the second quarter, with adjusted earnings per share topping Wall Street’s consensus forecast. CVS Health said Tuesday that for the second quarter ended June 30, sales climbed 17.6% to $43.73 billion from $37.17 billion
June 16, 2016 by Chain Drug Review
AHIP Institute and Expo, America's Health Insurance Plans, CVS Caremark, CVS Health, Larry Merlo, Troyen Brennan
Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health president and chief executive officer Larry Merlo is slated to deliver a keynote address today on public health challenges at the America’s Health Insurance Plans (AHIP) Institute and Expo in Las Vegas. Merlo, whose presentation is titled “Corporate America’s Role in Reducing Chronic Illness and Delivering Better Health,” is scheduled
May 3, 2016 by Chain Drug Review
CVS Health, CVS Pharmacy, Larry Merlo, Omnicare, Target Corp.
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I. — CVS Health reported strong sales gains and topped Wall Street’s consensus earnings forecast for the 2016 first quarter. CVS said Tuesday that for the three months ended March 31, overall revenue climbed 18.9% to $43.2 billion from $36.3 billion a year earlier. Sales in the Retail/LTC Segment, which includes CVS Pharmacy drug stores